United States
Print page content Print
Increase text size Decrease text size
Text Size

ZENIQUIN®

(marbofloxacin)

A convenient once - daily oral fluoroquinolone antibacterial for cats and dogs

Zeniquin

ZENIQUIN (marbofloxacin) Tablets are indicated for the treatment of skin and soft-tissue infections in dogs and cats and urinary tract infections in dogs with bacteria susceptible to marbofloxacin.

ZENIQUIN has the highest known tissue concentrations in the skin, kidney and lung compared with other veterinary-approved fluoroquinolones at the lowest recommended dose.1,2

Supplied:
25 mg scored tablets supplied in bottles that contain 100 or 250 tablets.
50 mg scored tablets supplied in bottles that contain 100 or 250 tablets.
100 mg scored tablets supplied in a 50 tablet bottle.
200 mg scored tablets supplied in a 50 tablet bottle.

Expand All
    • Convenient once-a-day dosing.
    • Scored and film-coated tablets are available in 4 sizes, providing flexible dosing for small to giant-sized breeds.
    • Target animal safety studies in cats did not demonstrate inducible dose-related ocular toxicity.+

    +The use of fluoroquinolones in cats has been reported to adversely affect the retina.

  • 1. ZENIQUIN US Prescribing Information. NADA #141-151. Zoetis Inc, 2001.

    2. Sheer M. Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet Med Rev. 1987;2:104-118.


IMPORTANT SAFETY INFORMATION:
ZENIQUIN is not recommended for use in immature cats or dogs during the rapid growth phase, or in cats or dogs known to be hypersensitive to fluoroquinolones. People with a history of hypersensitivity to fluoroquinolones should avoid this product.

See full Prescribing Information, attached.